Elevance Health's Q1 results showed stable Medicare utilization and reaffirmed guidance. Click here to find out why ELV stock ...

For full-year 2024, Elevance reported $175.2 billion in revenue, an increase of 2.9% over its $170.2 billion haul in 2023.

Despite rising costs in its health plans, Elevance Health reported more than $2 billion in first quarter net income thanks to growth across its health plans and Carelon health services ...

Gail Boudreaux; President, Chief Executive Officer, Director; Elevance Health Inc Mark Kaye; Chief Financial Officer, Executive Vice President; Elevance Health Inc Peter Haytaian; Executive ...

Elevance Health Inc. (NYSE: ELV) ended the first quarter of 2025 with better-than-expected financials. The company identified home health as one of its ...

Reports Q1 revenue $48.8B, consensus $46.25B. “At Elevance Health (ELV), our purpose-to improve the health of humanity-drives everything we do. In the first quarter, we made measurable progress ...

Elevance Health, Inc. ELV reported first-quarter 2025 adjusted earnings per share (EPS) of $11.97, which surpassed the Zacks Consensus Estimate by 6.8%. The bottom line increased 10.5% year over ...

Elevance Health Inc. spent less money on medical care than analysts expected in the first quarter, easing investor concerns after UnitedHealth Group Inc. reported ballooning costs. Elevance ...

In a report released today, Andrew Mok CFA from Barclays maintained a Buy rating on Elevance Health (ELV – Research Report), with a price ...